0001645113-21-000053.txt : 20210415 0001645113-21-000053.hdr.sgml : 20210415 20210415175918 ACCESSION NUMBER: 0001645113-21-000053 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210413 FILED AS OF DATE: 20210415 DATE AS OF CHANGE: 20210415 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Benaim Ely CENTRAL INDEX KEY: 0001632237 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37565 FILM NUMBER: 21829587 MAIL ADDRESS: STREET 1: C/O REXAHN PHARMACEUTICALS, INC. STREET 2: 15245 SHADY GROVE ROAD, SUITE 455 CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NovoCure Ltd CENTRAL INDEX KEY: 0001645113 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: NO. 4 THE FORUM STREET 2: GRENVILLE STREET CITY: ST. HELIER STATE: Y9 ZIP: JE2 4UF BUSINESS PHONE: 44 (0)15 3475 6700 MAIL ADDRESS: STREET 1: NO. 4 THE FORUM STREET 2: GRENVILLE STREET CITY: ST. HELIER STATE: Y9 ZIP: JE2 4UF FORMER COMPANY: FORMER CONFORMED NAME: Novocure Ltd DATE OF NAME CHANGE: 20150615 4 1 wf-form4_161852392575490.xml FORM 4 X0306 4 2021-04-13 0 0001645113 NovoCure Ltd NVCR 0001632237 Benaim Ely C/O NOVOCURE INC., 20 VALLEY STREAM PARKWAY, SUITE 300 MALVERN PA 19355 0 1 0 0 Chief Medical Officer Ordinary Shares 2021-04-13 4 M 0 1833 47.56 A 35092 D Ordinary Shares 2021-04-13 4 S 0 1833 200 D 33259 D Ordinary Shares 2021-04-13 4 M 0 651 83.30 A 33910 D Ordinary Shares 2021-04-13 4 S 0 651 200 D 33259 D Ordinary Shares 2021-04-13 4 M 0 3474 69.37 A 36733 D Ordinary Shares 2021-04-13 4 S 0 3474 200 D 33259 D Options to Buy Ordinary Shares 47.56 2021-04-13 4 M 0 1833 0 D 2029-05-07 Ordinary Shares 1833.0 10998 D Options to Buy Ordinary Shares 83.3 2021-04-13 4 M 0 651 0 D 2029-07-30 Ordinary Shares 651.0 3904 D Options to Buy Ordinary Shares 69.37 2021-04-13 4 M 0 3474 0 D 2030-03-02 Ordinary Shares 3474.0 19404 D Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Dr. Benaim. Fully vested as of the date hereof. By: /s/ Steven Robbins, Attorney in Fact for Ely Benaim 2021-04-15